Show:
Site
100
Phase I
What is the Phase of the study?
200
4 Sites
What is the number of sites?
300
Considering MSKCC, DFCI and SCRI
How many institutional sites versus community sites?
400
Access to neurologist
Is specialist accessible at the site?
500
Hematologist Oncologist
What is therapeutic expertise of the site?